About Depo-Provera Brain Tumor Cases
Recent studies have linked long-term use of Depo-Provera to an increased risk of developing brain tumors, particularly meningiomas.
What is Depo-Provera?
- Depo-Provera is a long-acting birth control injection containing medroxyprogesterone acetate. It's administered every three months and has been widely used since the 1990s.
- Recent research suggests that prolonged use may significantly increase the risk of developing brain tumors, particularly meningiomas.
The Link to Brain Tumors
- A 2024 study published in the British Medical Journal found that women who used Depo-Provera for 12 months or longer had a significantly increased risk of developing meningiomas.
- The risk appeared to increase with longer duration of use, with some studies showing up to a 5.6-fold increased risk.
Do You Qualify for Compensation?
Qualifying Criteria:
- Used Depo-Provera injections for 12+ months
- Diagnosed with meningioma or brain tumor
- Brain tumor developed during or after Depo use
- Medical records available
Potential Damages:
- Medical expenses (past and future)
- Lost wages and earning capacity
- Pain and suffering
- Emotional distress
Free, no-obligation case review
Why Choose MassTortsCo?
Since 2015, connecting qualified claimants with experienced mass tort attorneys.
Experienced Legal Network
Connected to leading mass tort law firms with proven track records in pharmaceutical litigation.
24/7 Support
Round-the-clock assistance to help you understand your rights and legal options.
No Upfront Costs
Your case review is free and there is no obligation. If you qualify, we connect you with a participating attorney.
Frequently Asked Questions (FAQ)
Signs and Symptoms to Watch For
- Persistent headaches
- Sudden vision problems
- Seizures
- Nausea and vomiting
- Balance or coordination issues
Who Qualifies for a Depo-Provera Lawsuit?
- You received two or more Depo-Provera injections
- You were diagnosed with a meningioma brain tumor
- You required surgery, radiation, or neurological care
Is There a Depo-Provera Settlement?
Yes. In July 2026, the defendants and the plaintiffs’ leadership signed a settlement agreement for eligible meningioma cases pending in the federal Depo-Provera litigation (MDL No. 3140). The court has said the program will give a substantial share of those plaintiffs the chance to resolve their claims, and that the agreement is not an admission of fault.
Individual payment amounts have not been made public. They are expected to depend on medical records, the treatment each person needed and the eligibility rules of the program. Be cautious of any website that quotes a dollar figure for your case.
The deadline for plaintiffs with pending cases to register for the program is November 30, 2026. New cases are still being filed, and an attorney can explain whether, and how, the settlement applies to a claim filed now.
Depo-Provera Lawsuit Timeline
- February 7, 2025 – Federal Depo-Provera brain tumor lawsuits are centralized in MDL No. 3140 before Judge M. Casey Rodgers in the Northern District of Florida
- December 2025 – The Depo-Provera label is updated to warn about meningioma
- Mid-2026 – The parties report an agreement in principle, and deadlines for the first bellwether trial are cancelled
- July 22, 2026 – The settlement agreement is signed
- August 10, 2026 – The court sets a November 30, 2026 registration deadline; more than 6,200 cases are pending
- November 2026 – The court approves the funds that will pay eligible claims; claims review and first payments are expected in 2027
Why the Depo-Provera Lawsuit Matters
- Accountability – Ensuring Pfizer faces responsibility for failing to warn patients
- Justice – Helping victims secure compensation for preventable health problems
- Awareness – Raising public knowledge about drug risks and FDA oversight gaps
Time is Critical - Act Now
If you used Depo-Provera and were diagnosed with a meningioma, a free review can tell you whether you may qualify. Filing deadlines vary by state.